gestational trophoblastic neoplasia

Publicação

Maternal and perinatal outcomes of first pregnancy after chemotherapy for gestational trophoblastic neoplasia in Brazilian women

Molar pregnancy in adolescents

Influence of hydatidiform mole follow-up setting on post-molar gestational trophoblastic neoplasia outcomes ? A cohort study

Gestational trophoblastic neoplasia in adolescents

Treatment of patients with gestational trophoblastic neoplasia (GTN) in 12 South America referral centers: Results after 10 years since international FIGO consensus

Epidemiological Report on the Treatment of Patients with Gestational Trophoblastic Disease in 10 Brazilian Referral Centers: Results After 12 Years Since International FIGO 2000 Consensus

Treatment of low-risk gestational trophoblastic neoplasia comparing biweekly eight-day Methotrexate with folinic acid versus bolus-dose Actinomycin-D, among Brazilian women

Hormonal contraceptive use before hCG remission does not increase the risk of gestational trophoblastic neoplasia following complete hydatidiform mole: a historical database review

Gestational trophoblastic neoplasia after spontaneous human chorionic gonadotropin normalization following molar pregnancy evacuation

Diagnosis, classification and treatment of gestational trophoblastic neoplasia

Changing Presentation of Complete Hydatidiform Mole at the New England Trophoblastic Disease Center over the Past Three Decades: Does Early Diagnosis Alter Risk for Gestational Trophoblastic Neoplasia?

Is chemotherapy necessary for patients with molar pregnancy and human chorionic gonadotropin serum levels raised but falling at 6months after uterine evacuation?

Complete molar pregnancy in adolescents from North and South America: Clinical presentation and risk of gestational trophoblastic neoplasia

Clinical and radiological correlations in patients with gestational trophoblastic disease

Changing Trends in the Clinical Presentation and Management of Complete Hydatidiform Mole Among Brazilian Women

Authors' reply re: Hormonal contraceptive use before hCG remission does not increase the risk of gestational trophoblastic neoplasia following a complete hydatidiform mole: a historical database review

Apoptotic index for prediction of postmolar gestational trophoblastic neoplasia

Uterine artery Doppler flow velocimetry parameters for predicting gestational trophoblastic neoplasia after complete hydatidiform mole, a prospective cohort study

The role of surgery in the management of women with gestational trophoblastic disease

Multiple pregnancies with complete mole and coexisting normal fetus in North and South America: A retrospective multicenter cohort and literature review

Is chemotherapy always necessary for patients with nonmetastatic gestational trophoblastic neoplasia with histopathological diagnosis of choriocarcinoma?

Does hormonal contraception during molar pregnancy follow-up influence the risk and clinical aggressiveness of gestational trophoblastic neoplasia after controlling for risk factors?

Management of symptomatic uterine arteriovenous malformations after gestational trophoblastic disease: The Brazilian experience and possible role for depot medroxyprogesterone acetate and tranexamic acid treatment

Clinical characteristics and thyroid function in complete hydatidiform mole complicated by hyperthyroidism

Gestational Trophoblastic Neoplasia after Ectopic Molar Pregnancy: Clinical, Diagnostic, and Therapeutic Aspects

Gestational Trophoblastic Neoplasia after Ectopic Molar Pregnancy: Clinical, Diagnostic, and Therapeutic Aspects

Does a human chorionic gonadotropin level of over 20,000-IU/L four weeks after uterine evacuation for complete hydatidiform mole constitute an indication for chemotherapy for gestational trophoblastic neoplasia?

Brazilian network for gestational trophoblastic disease study group consensus on management of gestational trophoblastic disease

Gestational Trophoblastic Disease in Brazil

Challenges in the diagnosis and treatment of gestational trophoblastic neoplasia worldwide

Can carboplatin or etoposide replace actinomycin-d for second-line treatment of methotrexate resistant low-risk gestational trophoblastic neoplasia?

Outcomes in the management of high-risk gestational trophoblastic neoplasia in trophoblastic disease centers in South America

How to optimize the management of gestational trophoblastic disease during the COVID era?

Gestational trophoblastic neoplasia lethality among Brazilian women: A retrospective national cohort study

Evaluation of high-dose vitamin A treatment in postmolar follow-up of patients with persistent low and plateauing serum human chorionic gonadotropin levels

Distinct microRNA profiles for complete hydatidiform moles at risk for malignant progression

Comparison of treatment for low-risk GTN with standard 8-day MTX/FA regimen versus modified MTX/FA regimen without chemotherapy on the weekend

Association between antioxidant vitamins and oxidative stress among patients with a complete hydatidiform mole

When less is more: regarding the use of chest X-ray instead of computed tomography in screening for pulmonary metastasis in postmolar gestational trophoblastic neoplasia

Uterine Rescue in High-Risk Gestational Trophoblastic Neoplasia Treated with EMA-CO by Uterine Arteries Embolization due to Arteriovenous Malformations

Predictors for single-agent resistance in FIGO score 5 or 6 gestational trophoblastic neoplasia: a multicentre, retrospective, cohort study

Perinatal outcomes of first pregnancy after chemotherapy for gestational trophoblastic neoplasia: a systematic review of observational studies and meta-analysis

Gestational trophoblastic neoplasia: one size does not fit all - Authors' reply

Folinic acid rescue during methotrexate treatment for low-risk gestational trophoblastic neoplasia - How much is just right?

Challenges in the Treatment of Low-risk Gestational Trophoblastic Neoplasia

A novel alternative to cytotoxic chemotherapy for gestational trophoblastic disease

Telemedicine in post-molar follow-up: is it a useful tool?

Emotional and Clinical Aspects Observed in Women with Gestational Trophoblastic Disease: A Multidisciplinary Action